Back to all studies
RecruitingNCT05878730

Melatonin and Response to Lithium

This study is recruiting. It focuses on bipolarity and currently lists participation information in France.

BipolarityDiagnostic TestFrom 18 Years to 70 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT05878730. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether urine collection may be useful for adults experiencing bipolarity.

What would participation involve?

Participants may complete study activities around urine collection, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in France.

Who is it mainly for?

This study appears to be mainly for adults with bipolarity.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Hôpital Fernand-Widal in Paris. Participation appears to center on assessments, scans, or samples rather than trying a new treatment. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results and pregnancy or breastfeeding. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: July 26, 2023
Recruitment status
Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Assistance Publique - Hôpitaux de Paris
Sponsor type
Unknown or unclear
Study type
Diagnostic Test
Intervention type
DIAGNOSTIC_TEST
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 70 Years
Official registry ID
NCT05878730
Official title
A Case-control Study Comparing Melatonin Nocturnal Secretion Between Lithium Responders Versus Non Responders in Type 1 Bipolar Disorder.
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT05878730. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help clarify how this condition is measured or understood.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in France.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring observational follow-up for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve biological samples, imaging, or biomarkers?

This appears to be a biological / biomarker / imaging study involving urine collection, Level of Proteins, Level of mRNA and miRNA, Level of plasmatic and intraerythrocytic lithium. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Do I need to want to stop or reduce tobacco use to participate?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may need to provide biological samples, complete lab tests, or take part in imaging or measurement procedures. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about samples, imaging, data, and possible discomfort?

If the study involves samples, imaging, or biomarkers, ask what is collected, how it is stored, who can access results, whether there may be discomfort, and whether results are shared with you. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Assistance Publique - Hôpitaux de Paris, which appears to be unknown or unclear. The listed contact or investigator is Assistance Publique - Hôpitaux de Paris, affiliated with Assistance Publique - Hôpitaux de Paris. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me